Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55.3 EUR | +0.18% | +1.10% | -1.95% |
Jul. 01 | US FDA Approves Formycon's Biosimilar to Treat Serious Retinal Diseases | MT |
Jun. 18 | Borse Frankfurt-News: Many winners and many losers (second-line stocks) | DP |
- Stock Market
- Equities
- FYB Stock
- News Formycon AG
- Transcripts